Pathways, practices and architecturesCitation formats

  • Authors:
  • Nik Brown
  • Christina Buse
  • Alan Lewis
  • Daryl Martin
  • Sarah Nettleton

Standard

Pathways, practices and architectures : Containing antimicrobial resistance in the cystic fibrosis clinic. / Brown, Nik; Buse, Christina; Lewis, Alan; Martin, Daryl; Nettleton, Sarah.

In: Health, 2019.

Research output: Contribution to journal › Article › peer-review

Harvard

Brown, N, Buse, C, Lewis, A, Martin, D & Nettleton, S 2019, 'Pathways, practices and architectures: Containing antimicrobial resistance in the cystic fibrosis clinic', Health. https://doi.org/10.1177/1363459319866894

APA

Brown, N., Buse, C., Lewis, A., Martin, D., & Nettleton, S. (2019). Pathways, practices and architectures: Containing antimicrobial resistance in the cystic fibrosis clinic. Health. https://doi.org/10.1177/1363459319866894

Vancouver

Brown N, Buse C, Lewis A, Martin D, Nettleton S. Pathways, practices and architectures: Containing antimicrobial resistance in the cystic fibrosis clinic. Health. 2019. https://doi.org/10.1177/1363459319866894

Author

Brown, Nik ; Buse, Christina ; Lewis, Alan ; Martin, Daryl ; Nettleton, Sarah. / Pathways, practices and architectures : Containing antimicrobial resistance in the cystic fibrosis clinic. In: Health. 2019.

Bibtex

@article{c45b8584feab4e509e358e2bcb6184a1,
title = "Pathways, practices and architectures: Containing antimicrobial resistance in the cystic fibrosis clinic",
abstract = "Antimicrobial resistance and the adaptation of microbial life to antibiotics are recognized as a major healthcare challenge. Whereas most social science engagement with antimicrobial resistance has focussed on aspects of {\textquoteleft}behaviour{\textquoteright} (prescribing, antibiotic usage, patient {\textquoteleft}compliance{\textquoteright}, etc.), this article instead explores antimicrobial resistance in the context of building design and healthcare architecture, focussing on the layout, design and ritual practices of three cystic fibrosis outpatient clinics. Cystic fibrosis is a life-threatening multi-system genetic condition, often characterised by frequent respiratory infections and antibiotic treatment. Preventing antimicrobial resistance and cross-infection in cystic fibrosis increasingly depends on the spatiotemporal isolation of both people and pathogens. Our research aims to bring to the fore the role of the built environment exploring how containment and segregation are varyingly performed in interaction with material design, focussing on three core themes. These include, first, aspects of flow, movement and the spatiotemporal choreography of cystic fibrosis care. Second, the management of waiting and the materiality of the waiting room is a recurrent concern in our fieldwork. Finally, we take up the question of air, the intangibility of airborne risks and their material mitigation in the cystic fibrosis clinic.",
author = "Nik Brown and Christina Buse and Alan Lewis and Daryl Martin and Sarah Nettleton",
year = "2019",
doi = "10.1177/1363459319866894",
language = "English",
journal = "Health",
issn = "1363-4593",
publisher = "Sage Publications Ltd",

}

RIS

TY - JOUR

T1 - Pathways, practices and architectures

T2 - Containing antimicrobial resistance in the cystic fibrosis clinic

AU - Brown, Nik

AU - Buse, Christina

AU - Lewis, Alan

AU - Martin, Daryl

AU - Nettleton, Sarah

PY - 2019

Y1 - 2019

N2 - Antimicrobial resistance and the adaptation of microbial life to antibiotics are recognized as a major healthcare challenge. Whereas most social science engagement with antimicrobial resistance has focussed on aspects of ‘behaviour’ (prescribing, antibiotic usage, patient ‘compliance’, etc.), this article instead explores antimicrobial resistance in the context of building design and healthcare architecture, focussing on the layout, design and ritual practices of three cystic fibrosis outpatient clinics. Cystic fibrosis is a life-threatening multi-system genetic condition, often characterised by frequent respiratory infections and antibiotic treatment. Preventing antimicrobial resistance and cross-infection in cystic fibrosis increasingly depends on the spatiotemporal isolation of both people and pathogens. Our research aims to bring to the fore the role of the built environment exploring how containment and segregation are varyingly performed in interaction with material design, focussing on three core themes. These include, first, aspects of flow, movement and the spatiotemporal choreography of cystic fibrosis care. Second, the management of waiting and the materiality of the waiting room is a recurrent concern in our fieldwork. Finally, we take up the question of air, the intangibility of airborne risks and their material mitigation in the cystic fibrosis clinic.

AB - Antimicrobial resistance and the adaptation of microbial life to antibiotics are recognized as a major healthcare challenge. Whereas most social science engagement with antimicrobial resistance has focussed on aspects of ‘behaviour’ (prescribing, antibiotic usage, patient ‘compliance’, etc.), this article instead explores antimicrobial resistance in the context of building design and healthcare architecture, focussing on the layout, design and ritual practices of three cystic fibrosis outpatient clinics. Cystic fibrosis is a life-threatening multi-system genetic condition, often characterised by frequent respiratory infections and antibiotic treatment. Preventing antimicrobial resistance and cross-infection in cystic fibrosis increasingly depends on the spatiotemporal isolation of both people and pathogens. Our research aims to bring to the fore the role of the built environment exploring how containment and segregation are varyingly performed in interaction with material design, focussing on three core themes. These include, first, aspects of flow, movement and the spatiotemporal choreography of cystic fibrosis care. Second, the management of waiting and the materiality of the waiting room is a recurrent concern in our fieldwork. Finally, we take up the question of air, the intangibility of airborne risks and their material mitigation in the cystic fibrosis clinic.

U2 - 10.1177/1363459319866894

DO - 10.1177/1363459319866894

M3 - Article

JO - Health

JF - Health

SN - 1363-4593

ER -